These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23066588)

  • 21. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
    Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
    Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 25. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Supervised injection. Under the watchful eye of nurses].
    Gagné L
    Perspect Infirm; 2013; 10(2):17-20. PubMed ID: 23539859
    [No Abstract]   [Full Text] [Related]  

  • 27. [Injection centers--new international experiences and Norwegian political debate].
    Gjesdal S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2785-7. PubMed ID: 15534677
    [No Abstract]   [Full Text] [Related]  

  • 28. Being realistic about benefits of supervised injecting facilities.
    Hall W; Kimber J
    Lancet; 2005 Jul 23-29; 366(9482):271-2. PubMed ID: 16039316
    [No Abstract]   [Full Text] [Related]  

  • 29. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemics of injecting drug use and blood-borne disease: a public health perspective.
    Gostin LO
    Spec Law Dig Health Care Law; 1998 Jun; (231):9-40. PubMed ID: 10181048
    [No Abstract]   [Full Text] [Related]  

  • 31. Minimising harm, maximising choice. Alcohol, drugs and rural youth.
    Lamp; 1997 Nov; 54(10):26-7. PubMed ID: 9444216
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime.
    Freeman K; Jones CG; Weatherburn DJ; Rutter S; Spooner CJ; Donnelly N
    Drug Alcohol Rev; 2005 Mar; 24(2):173-84. PubMed ID: 16076587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 34. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC).
    Goodhew M; Salmon AM; Marel C; Mills KL; Jauncey M
    Harm Reduct J; 2016 Oct; 13(1):29. PubMed ID: 27733167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of a heroin overdose prevention and education campaign.
    Horyniak D; Higgs P; Lewis J; Winter R; Dietze P; Aitken C
    Drug Alcohol Rev; 2010 Jan; 29(1):5-11. PubMed ID: 20078676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Sullivan LG
    Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
    [No Abstract]   [Full Text] [Related]  

  • 39. The Dr. Peter Centre. Harm reduction nursing.
    Wood RA; Zettel P; Stewart W
    Can Nurse; 2003 May; 99(5):20-4. PubMed ID: 12778610
    [No Abstract]   [Full Text] [Related]  

  • 40. Search interest in supervised injection sites in the United States following the opening of two clinics.
    Wilkins R; Perkins D; Weygandt J; Dunn K; Hartwell M
    J Osteopath Med; 2022 Mar; 122(6):329-330. PubMed ID: 35334191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.